151 related articles for article (PubMed ID: 14629747)
21. Multiple atypical adenomatous hyperplasia with synchronous multiple primary bronchioloalveolar carcinomas.
Kishi K; Homma S; Kurosaki A; Tanaka S; Matsushita H; Nakata K
Intern Med; 2002 Jun; 41(6):474-7. PubMed ID: 12135182
[TBL] [Abstract][Full Text] [Related]
22. Epidermal growth factor receptor mutation and p53 overexpression during the multistage progression of small adenocarcinoma of the lung.
Yoo SB; Chung JH; Lee HJ; Lee CT; Jheon S; Sung SW
J Thorac Oncol; 2010 Jul; 5(7):964-9. PubMed ID: 20512074
[TBL] [Abstract][Full Text] [Related]
23. Association of CYP19A1 polymorphisms with risks for atypical adenomatous hyperplasia and bronchioloalveolar carcinoma in the lungs.
Kohno T; Kakinuma R; Iwasaki M; Yamaji T; Kunitoh H; Suzuki K; Shimada Y; Shiraishi K; Kasuga Y; Hamada GS; Furuta K; Tsuta K; Sakamoto H; Kuchiba A; Yamamoto S; Kanai Y; Tsugane S; Yokota J
Carcinogenesis; 2010 Oct; 31(10):1794-9. PubMed ID: 20688833
[TBL] [Abstract][Full Text] [Related]
24. LAT1 expression in normal lung and in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
Nakanishi K; Matsuo H; Kanai Y; Endou H; Hiroi S; Tominaga S; Mukai M; Ikeda E; Ozeki Y; Aida S; Kawai T
Virchows Arch; 2006 Feb; 448(2):142-50. PubMed ID: 16175382
[TBL] [Abstract][Full Text] [Related]
25. Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas.
Sakamoto H; Shimizu J; Horio Y; Ueda R; Takahashi T; Mitsudomi T; Yatabe Y
J Pathol; 2007 Jul; 212(3):287-94. PubMed ID: 17534846
[TBL] [Abstract][Full Text] [Related]
26. Multiple lung adenocarcinomas and AAH treated by surgical resection.
Seki M; Akasaka Y
Lung Cancer; 2007 Feb; 55(2):237-40. PubMed ID: 17118487
[TBL] [Abstract][Full Text] [Related]
27. Atypical adenomatous hyperplasia and adenocarcinoma of the human lung: their heterology in form and analogy in immunohistochemical characteristics.
Mori M; Tezuka F; Chiba R; Funae Y; Watanabe M; Nukiwa T; Takahashi T
Cancer; 1996 Feb; 77(4):665-74. PubMed ID: 8616758
[TBL] [Abstract][Full Text] [Related]
28. Lung adenocarcinoma with bronchioloalveolar carcinoma component is frequently associated with foci of high-grade atypical adenomatous hyperplasia.
Koga T; Hashimoto S; Sugio K; Yonemitsu Y; Nakashima Y; Yoshino I; Matsuo Y; Mojtahedzadeh S; Sugimachi K; Sueishi K
Am J Clin Pathol; 2002 Mar; 117(3):464-70. PubMed ID: 11888087
[TBL] [Abstract][Full Text] [Related]
29. Targeted next-generation sequencing for analyzing the genetic alterations in atypical adenomatous hyperplasia and adenocarcinoma in situ.
Xu X; Li N; Zhao R; Zhu L; Shao J; Zhang J
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2447-2453. PubMed ID: 28821955
[TBL] [Abstract][Full Text] [Related]
30. Atypical adenomatous hyperplasia of the lung and its differentiation from adenocarcinoma. Characterization of atypical cells by morphometry and multivariate cluster analysis.
Mori M; Chiba R; Takahashi T
Cancer; 1993 Oct; 72(8):2331-40. PubMed ID: 8402446
[TBL] [Abstract][Full Text] [Related]
31. A case of double primary adenocarcinoma of the lung with multiple atypical adenomatous hyperplasia.
Anami Y; Matsuno Y; Yamada T; Takeuchi T; Nakayama H; Hirohashi S; Noguchi M
Pathol Int; 1998 Aug; 48(8):634-40. PubMed ID: 9736412
[TBL] [Abstract][Full Text] [Related]
32. [Preneoplastic lesions of pulmonary carcinoma].
Bubendorf L
Pathologe; 2011 Nov; 32 Suppl 2():218-23. PubMed ID: 22033683
[TBL] [Abstract][Full Text] [Related]
33. Expression of human telomerase RNA component and telomerase reverse transcriptase mRNA in atypical adenomatous hyperplasia of the lung.
Nakanishi K; Kawai T; Kumaki F; Hirot S; Mukai M; Ikeda E
Hum Pathol; 2002 Jul; 33(7):697-702. PubMed ID: 12196920
[TBL] [Abstract][Full Text] [Related]
34. A clinicopathological study of resected pulmonary nodules with focal pure ground-glass opacity.
Ohtsuka T; Watanabe K; Kaji M; Naruke T; Suemasu K
Eur J Cardiothorac Surg; 2006 Jul; 30(1):160-3. PubMed ID: 16723239
[TBL] [Abstract][Full Text] [Related]
35. [Atypical adenomatous hyperplasia].
Takaoka K
Ryoikibetsu Shokogun Shirizu; 1994; (4):20-2. PubMed ID: 8007130
[No Abstract] [Full Text] [Related]
36. Expression of cyclooxygenase-2, Fas and Fas ligand in pulmonary adenocarcinoma and atypical adenomatous hyperplasia.
Takigawa N; Ida M; Segawa Y; Nakata M; Mandai K; Kishino D; Fujiwara K; Saeki H; Takashima S; Eguchi K
Anticancer Res; 2003; 23(6D):5069-73. PubMed ID: 14981968
[TBL] [Abstract][Full Text] [Related]
37. Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung.
Hosomi Y; Yokose T; Hirose Y; Nakajima R; Nagai K; Nishiwaki Y; Ochiai A
Lung Cancer; 2000 Nov; 30(2):73-81. PubMed ID: 11086200
[TBL] [Abstract][Full Text] [Related]
38. Expressions of ATF6, XBP1, and GRP78 in normal tissue, atypical adenomatous hyperplasia, and adenocarcinoma of the lung.
Ogata S; Kameda K; Kono T; Ozeki Y; Hashimoto H; Tominaga S; Nakanishi K
Hum Pathol; 2019 Jan; 83():22-28. PubMed ID: 30121368
[TBL] [Abstract][Full Text] [Related]
39. Atypical alveolar hyperplasia: relationship with pulmonary adenocarcinoma, p53, and c-erbB-2 expression.
Kerr KM; Carey FA; King G; Lamb D
J Pathol; 1994 Dec; 174(4):249-56. PubMed ID: 7884586
[TBL] [Abstract][Full Text] [Related]
40. Synchronous double primary lung carcinomas associated with multiple atypical adenomatous hyperplasia.
Suzuki K; Takahashi K; Yoshida J; Nishimura M; Yokose T; Nishiwaki Y; Nagai K
Lung Cancer; 1998 Feb; 19(2):131-9. PubMed ID: 9567250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
